Analysis of Early Clinical Characteristics and Key Points for Identification and Early Warning of Lobar Pneumonia in Children
Objective: To analyze the early clinical characteristics and identification and warning points of lobar pneumonia in children. Methods: 86 children with lobar pneumonia in our hospital from October 2023 to April 2025 were selected; their clinical symptoms, signs, and examination data were analyzed; the typical and atypical clinical features of the early stage of the disease were summarized; and early warning indicators and identification points were analyzed. Results: The early symptoms of 86 children were mainly fever and cough, including 61 children with persistent high fever, 58 children with irritating dry cough and atypical early lung signs, and 29 children with positive signs such as rales in the lungs. Laboratory tests show that the peripheral blood white blood cell count and C-reactive protein of early-stage children will be abnormally elevated. Imaging examination is the main basis for early diagnosis. Chest CT of children can show segmental uniform dense infiltrates in the lung lobes. Children with listlessness, shortness of breath, persistent high fever, and significantly elevated inflammatory indicators have a significantly higher risk of disease progression (P < 0.05). Conclusion: The early clinical symptoms of lobar pneumonia in children lack specificity and the pulmonary signs are hidden. During the early clinical identification of the disease, persistent high fever, stubborn dry cough, abnormal inflammatory indicators and imaging changes can be considered, and combined with systemic symptoms and respiratory status, high-risk children can be screened, and early warning intervention can be carried out to promote the improvement of the prognosis of children.
[1] Zhu D, Zheng WT, Yao C, et al., 2024, Effects of Pediatric Feire Kechuan Granules Combined with Atomized Inhalation Acetylcysteine Solution on Pulmonary Ventilation Function, Inflammatory Factors and Immunoglobulins in Children with Bronchopneumonia. Progress in Modern Biomedicine, 24(4): 792–795.
[2] Yang H, Du JY, Yang MJ, et al., 2024, Predictive Value of Serum CXCL10 Combined with High-Resolution CT Imaging Features for Severe Mycoplasma Pneumonia in Children. Chinese Experimental Diagnostics, 28(12): 1411–1416.
[3] Xu SM, Zhang XW, Han XG, et al., 2023, Study on the Timing and Efficacy of Bronchoscopy in the Treatment of Lobar Mycoplasma Pneumonia. Chongqing Medicine, 52(10): 1464–1468.
[4] Song Y, Zhou SS, Dai SS, et al., 2025, Effectiveness of Alveolar Lavage Combined with Budesonide under Fiberoptic Bronchoscopy in the Treatment of Mycoplasma Pneumoniae Lobar Pneumonia in Children. Chinese Journal of Modern Medicine, 35(7): 21–26.
[5] Wang YY, Zhang LG, Feng SH, et al., 2025, The Efficacy of Bronchoalveolar Lavage under Fiberoptic Bronchoscopy in the Treatment of Lobar Pneumonia in Children and Its Impact on Inflammatory Factors in Children. Hainan Medicine, 36(24): 3566–3570.
[6] Yu CC, Huang SS, Wang C, et al., 2025, Analysis of the Clinical Value of High-Resolution CT in the Diagnosis of Mycoplasma Pneumoniae Pneumonia in Children. Imaging Research and Medical Applications, 9(1): 112–114.
[7] Lu XX, Zhang R, 2025, The Predictive Value of Early Monitoring of Serum FGF-23 and Myocardial Enzyme Spectrum Levels for Myocardial Damage Complicated by Lobar Pneumonia in Children. Chinese Journal of Frontier Health and Quarantine, 48(3): 297–300.
[8] Lu TL, Peng XQ, Sun X, 2024, Correlation Analysis of Peripheral Blood EOS, IL-17A, TNF-α, VEGF and Mycoplasma Pneumoniae Infection in Children with Wheezing. International Journal of Laboratory Medicine, 45(10): 1188–1192.
